Valneva and Dynavax Collaborate to Develop COVID-19 Vaccine Post author:Sam Post published:April 23, 2020 Post category:Devices & Diagnostics Letter Dynavax used the adjuvant in its FDA-approved hepatitis B vaccine. Source: Devices & Diagnostics Letter You Might Also Like Glenmark’s Favipiravir Shows Promise for COVID-19 Patients July 22, 2020 FDA Grants Priority Review for Liso-Cel in B-cell Lymphoma February 24, 2020 MHRA Temporarily Eases Some GMP Requirements April 23, 2020